Startup profile · funding coverage
Oppex AI funding, valuation and investors
AI SRE and on-call product Nova with automatic investigation, incident response and guarded remediation.
Verified company research · funding, investors and latest developments
Keep track of Oppex AI
Save this profile to your VCT watchlist for a quick return.
Funding, valuation & investors
Answer-first snapshotLatest funding
Not publicly disclosed
Latest known valuation
Not publicly disclosed
Total disclosed equity funding
Not publicly disclosed
Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.
Current status
private
Stage not recorded
Overview
Oppex AI promotes an incident platform with Nova, an AI SRE agent integrating production telemetry and on-call workflows. Its 2026 product guide advertises triage, root-cause hypotheses, evidence references and remediation with approval controls, plus commercial self-serve tiers. This is vendor-provided positioning, not an independent evidence benchmark.
VCT has not confirmed disclosed venture financing and therefore does not invent investment rounds or valuation. Buyers should assess source connectors, whether an investigation has reproducible evidence, human approval options and production authority boundaries.
Why Oppex AI is interesting
Oppex is a lower-ticket, integrated incident/on-call alternative worth comparing against enterprise-contract AI SRE vendors; price claims must be refreshed before purchase.
Product & use cases
Nova AI SRE with incident workflow, paging and integrated diagnostics; pricing and capabilities per company product literature.
- Automate alert investigation
- Coordinate on-call escalation
- Propose supervised remediations
Competitive landscape
Edge: Integrated lower-ticket SRE and on-call packaging versus enterprise-contract agent platforms; capabilities need technical validation.
The closest alternatives differ by whether they investigate existing telemetry, orchestrate incidents, evaluate AI agent behavior, or prevent adversarial exploitation. Selection should be based on representative task-level tests, deployment permissions, data control and total ownership cost.
-
Rootly direct
On-call plus AI SRE
-
Traversal direct
Standalone AI SRE diagnosis
-
Cleric direct
Read-only incident investigation
Industries
Market / IPO context
Editorial / static context — not a live quote.
FAQs about Oppex AI
Practical answers founders, operators, and investors typically search for.
Last updated:
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.